Evidence map›Paper›PMID 40991201›Full record

ReviewCell biochemistry and biophysics2026

Linking SIRT1 Variants to Metabolic and Cardiovascular Phenotypes: Insights from Population Genetics and In Silico Structural Analysis.

Eugene S Grebenshchikov, Anna E Pravednikova, Evgeny E Bezsonov, Denis S Kudryavtsev, Svetlana N Larina, Yulii V Shidlovskii

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eugene S GrebenshchikovLaboratory of Gene Expression Regulation in Development, Institute of Gene Biology RAS, Moscow, Russia. grebenshchikov_e_s@staff.sechenov.ru.ORCID http://orcid.org/0000-0002-3644-5138
Anna E PravednikovaLaboratory of Gene Expression Regulation in Development, Institute of Gene Biology RAS, Moscow, Russia.ORCID http://orcid.org/0000-0002-4572-5318
Evgeny E BezsonovDepartment of Biology and General Genetics, Federal State Autonomous Educational Instution of Нigher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID http://orcid.org/0000-0002-9382-8338
Denis S KudryavtsevDepartment of Biology and General Genetics, Federal State Autonomous Educational Instution of Нigher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID http://orcid.org/0000-0002-0313-9193
Svetlana N LarinaDepartment of Biology and General Genetics, Federal State Autonomous Educational Instution of Нigher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID http://orcid.org/0000-0003-0188-543X
Yulii V ShidlovskiiLaboratory of Gene Expression Regulation in Development, Institute of Gene Biology RAS, Moscow, Russia.ORCID http://orcid.org/0000-0002-3643-9889

Funding

This study was supported by the Russian Science Foundation project 23-14-00348
6 · The paper itself

Abstract

The sirtuin (SIRT) family, particularly SIRT1, plays a pivotal role in cell metabolism, inflammation, and aging through its NAD+-dependent deacetylase activity. SIRT1 modulates signaling pathways by targeting numerous regulatory proteins and transcription factors (TFs). Among these is the forkhead TF FOXO1, which plays a key role in regulating genes associated with inflammation (TNF-α), oxidative stress, and glucose and lipid metabolism (G6Pase and PPARG). SIRT1 additionally regulates other important TFs involved in inflammation and cancer, such as HIF-1α, HIF-2α, and p53, all of which are directly associated with lifespan. Here we describe the association between SIRT1 gene variants and various pathologic conditions in different population groups (African, European, and Asian). We discuss the association of SIRT1 polymorphisms with cardiovascular health, lifespan, and diseases, including metabolic disorders, obesity, hypertension, and systemic lupus erythematosus, emphasizing their relevance for personalized medicine. Our findings highlight the dual role of SIRT1 in metabolic regulation, where its overexpression can both protect against insulin resistance and disrupt lipid homeostasis. Additionally, using the variant rs587776957 as an example, we evaluated its effect on the secondary structure of the protein. Our in silico analysis assessed the effect of the polymorphism on the protein’s structural stability, confirming its potential to destabilize the secondary structure of SIRT1. The primary goal of this study was a comprehensive assessment of the clinical significance of SIRT1 gene genetic variants across different populations, with a particular focus on their role in regulating metabolism, lifespan, and cardiovascular health. To achieve this, we combined a review and bioinformatic analysis of population-specific associations with an in-depth in silico investigation analyzing the structural impact of the rs587776957 variant on the SIRT1 protein.

Indexed as

Cardiovascular DiseasesSirtuin 1Computer SimulationGenetics, PopulationHumansPhenotypePolymorphism, Single NucleotideProtein Structure, SecondarySIRT1 protein, humanSirtuin 1Cardiovascular diseasesLifespanMetabolismSIRT1Sirtuins

Identifiers

PMID40991201

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.